Covid-19 Information

This page was produced at the start of the COVID-19 pandemic.

The vast majority of the contents of this page has been archived. If you require access to any of the material that was previously held on this page please contact a member of the Medicines Optimisation team at BLMKICB.MedsOpt@nhs.net

Covid Medicines Delivery Unit (CMDU)

Antiviral medicines for the treatment of non-hospitalised patients with coronavirus (COVID-19) infection are available via the COVID medicines delivery unit (CMDU) in BLMK where the following criteria are met:

patient falls within the ‘highest risk’ group as defined in the NICE technology appraisal (see links below)
patient aged 85 years or over
patient with end-stage heart failure who has long term ventricular assistance device
patient on the organ transplant waiting list
patient resident in a care home and 70 years and over or BMI of 35kg/m² or more, diabetes or heart failure
patient is symptomatic, showing no signs of clinical improvement and their symptom onset is predominantly within 5 days
patient has COVID-19 infection confirmed with a positive lateral flow test

These treatments are accessible through the CMDU multidisciplinary clinical triage team, who receive completed referral forms, assess and prescribe, if clinically indicated and in line with the NICE clinical guidelines.

If a patient is identified as meeting the clinical criteria they should be referred into the CMDU clinical triage team for review via email (see referral forms below).

Please see below for further information on the BLMK CMDU.

Page updated April 2024